{"title":"Trends in Long-term Survival After Acute Ischemic Stroke Among Medicare Beneficiaries: Population-based Cohort Study.","authors":"Xin Tong, Robert K Merritt, Susan A Carlson","doi":"10.1016/j.amepre.2026.108597","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Few studies have examined temporal trends in long-term survival after acute ischemic stroke (AIS) across demographic groups. This study examined long-term survival trends among Medicare fee-for-service (FFS) beneficiaries hospitalized with AIS during 2000-2019, with follow-up through 2024.</p><p><strong>Methods: </strong>This study analyzed data from 2,118,429 FFS beneficiaries aged ≥66 years hospitalized with incident AIS between January 1, 2000, and December 31, 2019. The cohort was categorized into four time periods: 2000-2004, 2005-2009, 2010-2014, and 2015-2019. Adjusted 1- and 5-year survival were estimated using Cox proportional hazards model across age, sex, race and ethnicity and Charlson Comorbidity Index (CCI) categories. Trends were assessed using average annual percent change (AAPC) via Joinpoint regression.</p><p><strong>Results: </strong>From 2000-2004 to 2015-2019, adjusted 1- and 5-year stroke survival increased significantly from 80.3% to 83.4% (AAPC: 0.22%), and from 46.1% to 52.2% (AAPC: 0.75%), respectively. Survival increased across all age groups, both sexes, all race and ethnicity categories, and CCI categories. Beneficiaries aged ≥75 years showed greater annual increases in 1-year survival than those aged 66-74 years. Black beneficiaries had greater increases in 1-year survival than White beneficiaries, although their survival remained lower. Beneficiaries with more comorbidities (CCI ≥2) had greater improvements compared to those without comorbidities, though they maintained lower survival.</p><p><strong>Conclusions: </strong>Long-term survival after AIS improved significantly for Medicare FFS beneficiaries over time. However, the varying degrees of improvement and the persistent differences across demographic groups highlight the need for focused and tailored strategies to reduce differences in stroke outcomes.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108597"},"PeriodicalIF":4.7000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2026.108597","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Few studies have examined temporal trends in long-term survival after acute ischemic stroke (AIS) across demographic groups. This study examined long-term survival trends among Medicare fee-for-service (FFS) beneficiaries hospitalized with AIS during 2000-2019, with follow-up through 2024.
Methods: This study analyzed data from 2,118,429 FFS beneficiaries aged ≥66 years hospitalized with incident AIS between January 1, 2000, and December 31, 2019. The cohort was categorized into four time periods: 2000-2004, 2005-2009, 2010-2014, and 2015-2019. Adjusted 1- and 5-year survival were estimated using Cox proportional hazards model across age, sex, race and ethnicity and Charlson Comorbidity Index (CCI) categories. Trends were assessed using average annual percent change (AAPC) via Joinpoint regression.
Results: From 2000-2004 to 2015-2019, adjusted 1- and 5-year stroke survival increased significantly from 80.3% to 83.4% (AAPC: 0.22%), and from 46.1% to 52.2% (AAPC: 0.75%), respectively. Survival increased across all age groups, both sexes, all race and ethnicity categories, and CCI categories. Beneficiaries aged ≥75 years showed greater annual increases in 1-year survival than those aged 66-74 years. Black beneficiaries had greater increases in 1-year survival than White beneficiaries, although their survival remained lower. Beneficiaries with more comorbidities (CCI ≥2) had greater improvements compared to those without comorbidities, though they maintained lower survival.
Conclusions: Long-term survival after AIS improved significantly for Medicare FFS beneficiaries over time. However, the varying degrees of improvement and the persistent differences across demographic groups highlight the need for focused and tailored strategies to reduce differences in stroke outcomes.
期刊介绍:
The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.
Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.